Key result
Chemogenetic cholinergic activation cuts action potential duration ~16% and improves rate adaptation in heart failure.
Why the study?
LV electrical maladaptation to increased heart rate in failing myocardium contributes to morbidity and mortality, prompting investigation into whether chronic cardiac cholinergic neuron activation reduces TAC-induced derangement of cardiac electrical activity.
Does chronic cholinergic stimulation improve electrophysiological rate adaptation in a rat model of pressure overload-induced heart failure?
Does chronic cholinergic stimulation improve electrophysiological rate adaptation in a rat model of pressure overload-induced heart failure?
Absolute Event Rate: 65.46% vs 78.27%
p-value: p=0.0220
Chronic cholinergic stimulation blunts maladaptive electrophysiological changes in failing myocardium, suggesting a potential anti-arrhythmic benefit for heart failure patients.
BACKGROUND: Left ventricular (LV) electrical maladaptation to increased heart rate in failing myocardium contributes to morbidity and mortality. Recently, cardiac cholinergic neuron activation reduced loss of contractile function resulting from chronic trans-aortic constriction (TAC) in rats. We hypothesized that chronic activation of cardiac cholinergic neurons would also reduce TAC-induced derangement of cardiac electrical activity. METHODS: We investigated electrophysiological rate adaptation in TAC rat hearts with and without daily chemogenetic activation of hypothalamic oxytocin neurons for downstream cardiac cholinergic neuron stimulation. Sprague Dawley rat hearts were excised, perfused, and optically mapped under dynamic pacing after 16 weeks of TAC with or without 12 weeks of daily chemogenetic treatment. Action potential duration (APD60) and conduction velocity (CV) maps were analyzed for regional rate adaptation to dynamic pacing. RESULTS: At lower pacing rates, untreated TAC induced elevated LV epicardial APD60. Fitted APD60 steady state (APDss) was reduced in treated TAC hearts. At higher pacing rates, treatment heterogeneously reduced APD60 compared to untreated TAC hearts. Variance of conduction loss was reduced in treated hearts compared to untreated hearts during fast pacing. However, CV was markedly reduced in both treated and untreated TAC hearts throughout dynamic pacing. At 150msec pacing cycle length, APD60 v. diastolic interval (DI) dispersion was reduced in treated hearts compared to untreated hearts. CONCLUSIONS: Chronic activation of cardiac cholinergic neurons improved electrophysiological adaptation to increases in pacing rate during development of TAC-induced heart failure. This provides insight into the electrophysiological benefits of cholinergic stimulation as a treatment for heart failure patients.
No takes yet. Share an insight, caveat, or question.
Zasadny et al. (2020) studied Pressure overload-induced heart failure (TAC model) (n=19). Chemogenetic activation of hypothalamic oxytocin neurons (DREADDs + CNO) vs. Untreated TAC (saline) was evaluated on Action potential duration steady state (APDss) (p=0.0220). Chronic chemogenetic activation of cardiac cholinergic neurons reduced APD60 steady state (65.46 vs 78.27 ms, p=0.0220) and improved electrophysiological rate adaptation in TAC-induced heart failure rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: